Table 4.
Regression analysis for central retinal arteriolar and retinal venular equivalent.
| CRAE | CRVE | ||||||
|---|---|---|---|---|---|---|---|
| (μm per unit change) | (μm per unit change) | ||||||
| β (95% CI) | p-value | R2 | β (95% CI) | p-value | R2 | ||
| BMI z score | −2.489 (−6.037–1.059) | 0.168 | 0.153 | BMI z score | −2.814 (−7.198–1.570) | 0.207 | 0.028 |
| Plasma glucose, mmol/L | 6.029 (1.016–11.042) | 0.019 | C-reactive protein, mg/L | 0.674 (−0.252–1.599) | 0.152 | ||
| LDL-cholesterol, mmol/L | −2.913 (−6.234–0.408) | 0.085 | HOMA-IR | 0.701 (−0.197–1.598) | 0.125 | ||
| ICAM-1, μg/mL | 0.019 (−0.007–0.045) | 0.149 | HbA1c, % | 0.213 (−9.005–9.430) | 0.964 | ||
| VCAM-1, μg/mL | 0.006 (−0.013–0.025) | 0.509 | |||||
| Systolic blood pressure z score | −0.420 (−3.136–2.296) | 0.760 | |||||
| Diastolic blood pressure z score | −2.848 (−5.400–0.296) | 0.029 | |||||
Data represented as unstandardized regression coefficient (95% CI); CRAE = central retinal arteriolar equivalent; CRVE = central retinal venular equivalent; ICAM-1 = intracellular adhesion molecule 1; VCAM-1 = vascular adhesion protein 1; HOMA-IR = Homeostatic Model Assessment of Insulin Resistance.